Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saw Palmetto extract in CP/CPPS
ChiCTR-IPR-16010196Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Prostatodynia (CP/CPPS) comparing Saw Palmetto extract with Placebo (2 arms). Primary endpoints: NIH-CPSI and IIEF-5. Started Jan 2017; status: completed.
02
Drugs
saw palmetto fruit extract
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on ChiCTR-IPR-16010196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16010196.